BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kebebe D, Wu Y, Zhang B, Yang J, Liu Y, Li X, Ma Z, Lu P, Liu Z, Li J. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer. Int J Nanomedicine 2019;14:6179-95. [PMID: 31447559 DOI: 10.2147/IJN.S202424] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang B, Zhang Y, Dang W, Xing B, Yu C, Guo P, Pi J, Deng X, Qi D, Liu Z. The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01628-x] [Reference Citation Analysis]
2 Chen X, Zhang S, Li J, Huang X, Ye H, Qiao X, Xue Z, Yang W, Wang T. Influence of Elasticity of Hydrogel Nanoparticles on Their Tumor Delivery. Adv Sci (Weinh) 2022;:e2202644. [PMID: 35981891 DOI: 10.1002/advs.202202644] [Reference Citation Analysis]
3 Gupta U, Saren BN, Khaparkhuntikar K, Madan J, Singh PK. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer. J Control Release 2022;348:1089-115. [PMID: 35640765 DOI: 10.1016/j.jconrel.2022.05.034] [Reference Citation Analysis]
4 Wang L, Zhu S, Zou C, Kou H, Xu M, Li J. Preparation and evaluation of the anti-cancer properties of RGD-modified curcumin-loaded chitosan/perfluorohexane nanocapsules in vitro. Heliyon 2022;8:e09931. [PMID: 35865990 DOI: 10.1016/j.heliyon.2022.e09931] [Reference Citation Analysis]
5 Rana S, Bhatnagar A, Singh S, Prabhakar N. Evaluation of liver specific ionizable lipid nanocarrierin the delivery of siRNA. Chem Phys Lipids 2022;:105207. [PMID: 35623403 DOI: 10.1016/j.chemphyslip.2022.105207] [Reference Citation Analysis]
6 Chaudhuri A, Kumar DN, Dehari D, Singh S, Kumar P, Bolla PK, Kumar D, Agrawal AK. Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 2022;15:542. [DOI: 10.3390/ph15050542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Dang W, Guo P, Song X, Zhang Y, Li N, Yu C, Xing B, Liu R, Jia X, Zhang Q, Feng X, Liu Z. Nuclear Targeted Peptide Combined With Gambogic Acid for Synergistic Treatment of Breast Cancer. Front Chem 2022;9:821426. [DOI: 10.3389/fchem.2021.821426] [Reference Citation Analysis]
8 Li S, Xu Z, Alrobaian M, Afzal O, Kazmi I, Almalki WH, Altamimi ASA, Al-Abbasi FA, Alharbi KS, Altowayan WM, Singh T, Akhter MH, Gupta M, Rahman M, Beg S. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma. Biotechnol Appl Biochem 2021. [PMID: 34775646 DOI: 10.1002/bab.2279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ren L, Nie J, Wei J, Li Y, Yin J, Yang X, Chen G. RGD-targeted redox responsive nano micelle: co-loading docetaxel and indocyanine green to treat the tumor. Drug Deliv 2021;28:2024-32. [PMID: 34569890 DOI: 10.1080/10717544.2021.1977425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wang M, Li H, Huang B, Chen S, Cui R, Sun ZJ, Zhang M, Sun T. An Ultra-Stable, Oxygen-Supply Nanoprobe Emitting in Near-Infrared-II Window to Guide and Enhance Radiotherapy by Promoting Anti-Tumor Immunity. Adv Healthc Mater 2021;10:e2100090. [PMID: 33885213 DOI: 10.1002/adhm.202100090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Sartaj A, Baboota S, Ali J. Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast cancer. Journal of Drug Delivery Science and Technology 2021;63:102451. [DOI: 10.1016/j.jddst.2021.102451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ma Z, Pi J, Zhang Y, Qin H, Zhang B, Li N, Li Z, Liu Z. Enhanced Anticancer Efficacy of Dual Drug-Loaded Self-Assembled Nanostructured Lipid Carriers Mediated by pH-Responsive Folic Acid and Human-Derived Cell Penetrating Peptide dNP2. Pharmaceutics 2021;13:600. [PMID: 33921919 DOI: 10.3390/pharmaceutics13050600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Ma Z, Li N, Zhang B, Hui Y, Zhang Y, Lu P, Pi J, Liu Z. Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality. J Nanobiotechnology 2020;18:123. [PMID: 32887626 DOI: 10.1186/s12951-020-00681-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Hatami E, Jaggi M, Chauhan SC, Yallapu MM. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics. Biochim Biophys Acta Rev Cancer 2020;1874:188381. [PMID: 32492470 DOI: 10.1016/j.bbcan.2020.188381] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]